Autres langues Shanghai Pharmaceuticals Holding Co., Ltd Other OTC

Actions

SHPMY

US81943R1005

Produits pharmaceutiques

Autres langues

11/09	Shanghai Pharmaceuticals Subsidiary Gets China Approval for Antibiotic
11/09	Shanghai Pharmaceuticals Declares Interim Dividend
01/09	Shanghai Pharmaceuticals Uniti Gets China Drug Registration Nod for Blood Cancer Tablets
27/08	Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026
27/08	Shanghai Pharma Posts Lower H1 Attributable Profit; Revenue Up
27/08	Shanghai Pharmaceuticals Holding Co., Ltd Announces Interim Ordinary Cash Dividend for the Six Months Ended 30 June 2026, Payable on 23 October 2026
25/08	Shanghai Pharmaceuticals to Dispose of Pharmaceutical Retail Subsidiary Through Public Listing
25/08	Shanghai Pharmaceuticals Gets China Supplementary Approval for Skin Allergy Injection
04/08	Hong Kong Stocks Fall on Tuesday as Middle East Uncertainty Weighs; HSBC Slips Despite Profit Rise
04/08	Shanghai Pharmaceuticals' Unit Received Registration Certificate for Omeprazole, Sodium Bicarbonate for Oral Suspension
31/07	Shanghai Pharmaceuticals Unit Gets Canada Product Licenses for Three Products
31/07	Shanghai Pharmaceuticals Subsidiary Gets China Drug Registration Certificate for High Cholesterol Tablets
27/07	Shanghai Pharmaceuticals Ends Clinical Trial on Salvianolic Acid A for Injection
21/07	Shanghai Pharmaceuticals Unit Gets China Clinical Trial Approval for Dry Eye Drug
20/07	Shanghai Pharmaceuticals Arm to Divest 41% Stake in Subsidiary Through Public Listing
20/07	Shanghai Pharmaceuticals Commits 300 Million Yuan in Biomedicine Fund
30/06	Shanghai Pharmaceuticals Subsidiary Gets Supplementary Drug Approval for Anti-Organ Rejection Tablets
30/06	Shanghai Pharmaceuticals Gets China Approval for Spasm Drug for Infants
25/06	Shanghai Pharmaceuticals Holding Co., Ltd Announces Management and Committees Changes
25/06	Shanghai Pharmaceuticals Holding Co., Ltd Approves Dividend for the Year 2025, Payable on 24 August 2026
17/06	Shanghai Pharmaceuticals Holding Co., Ltd. Elects Zhao Yong as Employee Representative Director
15/06	Shanghai Pharmaceuticals Gets Nod for Manufacturing of Roxadustat Capsules
12/06	Shanghai Pharmaceuticals Holding Co., Ltd(SHSE:601607) dropped from SSE 180 Index
03/06	Shanghai Pharmaceuticals Holding Co., Ltd Proposes to Pay Cash Dividends in the Half Year of 2026
27/05	Shanghai Pharmaceuticals nominates Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming as exec directors of ninth board session